Science Group hikes share buyback programme despite dip in revenue July 23, 2024 Record profit first half profit at Science Group driven by a well choreographed turnaround at one of its major brands helped the consultancy and systems specialist to increase its share buyback programme.
City sounds alarm on health of London’s AIM market as listings hit 20-year low July 23, 2024 Leading City figures have sounded the alarm over the health of London's AIM market after a new analysis revealed the number of companies quoted on London's junior market to be at a 20-year low.
Beeks: Cloud firm ‘delighted’ with ‘record’ financial results July 22, 2024 Financial cloud computing firm Beeks hailed its delivery of another year of double digit growth thanks to its "strong" performance across its private and exchange cloud divisions.
Harland & Wolff slams ‘misleading’ claims government won’t back £200m loan July 17, 2024 Troubled shipbuilder Harland & Wolff has dismissed reports that the government will reject its request for a £200m loan guarantee.
Cohort: Defence firm has record revenue and bumper order book amid ‘persistent’ tensions July 17, 2024 Defence holding group Cohort pointed to the invasion of Ukraine and "persistent" tensions in the Aisa-Pacific region as being the core drivers of the record revenue and bumper profit it posted in its preliminary results.
Gateley’s nine year streak of revenue growth continues despite dented profits July 16, 2024 Legal and professional services group Gateley has extended of its unbroken run of revenue growth since IPO in 2015, but saw a small slide in profit after reinstating its employee bonus.
Eco Animal Health beats expectations thanks to Americas growth July 15, 2024 Animal vaccine firm Eco Animal Health beat earnings expectations despite continuing volatility in currency, thanks largely to its "robust" demand for its flagship vaccine and consistent market leading position.
Concurrent Technologies reveals ‘record results’ as profit doubles July 15, 2024 Computer product manufacturer Concurrent Technologies looks set to report "record results" in the first six months of its financial year following a swathe of new client wins.
Destiny Pharma is latest to leave London in pursuit of private funding July 15, 2024 Biotech business Destiny Pharma has become the latest firm to de-list from the London Stock Exchange after it said it would have access to a "larger pool of capital" as a private company.
System1: US sales soar as demand for advert testing continues to grow July 12, 2024 Ad testing firm System1 has seen its revenue soar following a jump in its US sales, marking an "exceptionally strong" start to its financial year.